AutoCruitment的动态

?? Healthcare’s landscape keeps moving, and this week’s Wrap-Up from Vault highlights the strategic updates everyone in the field needs to follow, including how recent moves in digital health, AI applications, and new collaborations are setting the stage for change. ??Insights: Pfizer’s latest work with major insurers opens up discussions about long-term strategies in patient access. Developments from IBM and NVIDIA show new approaches to diagnostics—but data security is under a fresh spotlight. Chronic care models are evolving rapidly, with organizations like Mayo Clinic leading the way in setting new standards for patient engagement. ?? These aren’t just updates; they’re cues for forward-thinking strategies that will shape our industry. Check out these stories and more ????

Welcome to the forefront of healthcare #innovation! SEQSTER and Atropos Health have joined forces with a common goal: to address the pressing challenges of diversity and inclusion in clinical trials. With our pioneering partnership, we establish turnkey patient registries in less than 48 hours ?? Real World Evidence is now possible through Generative AI?? If you're interested in using patient registries to accelerate #clinicaltrials and enhance patient care, reach out to us today! Let us help you unlock the potential of real-world evidence and drive innovation at your organization. Check out the latest Press from MedCity News below! #DigitalHealth #SeqsterOS #RegulatoryGradeData #GenerativeAi #RWD #RWE https://lnkd.in/gCuhU5V7

Being able to provide Brick-and-Mortar(offline) + DCT(Online) patient experience, Walgreen is trying become a Site + CRO. 1. Enhancing patient recruitment with access to 130 million individuals data and AI. 2. Enabling DCT/Hybrid infrastructure for trials. 3. Spreading awareness about clinical trials to enhance inclusivity. #EHRDataForClinicalResearch https://lnkd.in/dxHHuAhS

So... Lots going on re EMR analysis / AI for patient recruitment, but we still know that building relationships with potentially eligible patients / onboarding the right way is so important (shout out to the great study coordinators and PIs out there!). Is EMR analysis the main game? Is better patient onboarding the main game? Please check out (and like/promote) my latest column in Applied Clinical Trials that focuses on challenges / debates in clinical trial recruitment. Special thanks to Brett Kleger and Elisa Cascade for their contributions!

Are you ready to rethink how we approach patient recruitment in clinical trials? Hugo Stephenson, CEO of TrialScreen in his first installment as a regular contributor in Applied Clinical Trials Magazine, dove deep into the critical question: Is clinical trial recruitment primarily a data problem or a trust challenge? He sat down with two industry leaders to unpack this complex issue: Brett Kleger, CEO of Inspire, shared a powerful insight: "While data can tell us who might be eligible, it doesn't necessarily tell us who will participate. There's a human element that can't be captured by algorithms alone." Elisa Cascade, Chief Product Officer at Advarra, added nuance, noting that the approach varies by trial type: "One of the greatest drivers of clinical trial interest was a patient's lack of satisfaction with their medication, including bothersome side effects." Read the full article ? https://bit.ly/3ACPI4t At TrialScreen, we're committed to bridging the gap between data-driven insights and trust-based relationships in North America, Latin America and Asia/Pacific. Our mission is to create more inclusive and efficient trials that accelerate the development of life-changing therapies. Join us in transforming the landscape of clinical trial recruitment! #ClinicalTrials #PatientRecruitment #DataAndTrust #HealthTech #TrialScreen

??AI company Spectral AI, which is focused on medical diagnostics for faster and more accurate treatment decisions in wound care, has added two new U.S. Clinical Trial Sites for its 2024 Burn Pivotal Study. ?? “These two new sites allow us to capture additional burn patients who enter through the Emergency Department and thus complement our existing trial site presence at burn centers across the country, establish our presence in new geographies, and advance us towards our objective of completing this study by the end of the year,” said Pete Carlson, Chief Executive Officer of Spectral AI. ?? Read more: https://lnkd.in/dr27-zwD ?? Follow Guided Solutions to receive the latest #MedTech news daily and subscribe to our weekly newsletter: https://lnkd.in/dSZYQ_cn #MedicalDevices #MedicalDevice #MedicalEquipment #Medicine #HealthTech #Surgeons #GuidedSolutions

?? ?? News for everyone involved in healthcare data cleaning and Electronic Health Record (EHR) systems! ?? Yonalink successfully used AI to map and stream data from EHR-to-EDC (i.e. clinical trial database) in real time across 21 medical centers! ?? 93% of the data was mapped and transferred with 100% accuracy of information! ?? This is a massive breakthrough that gets us one step closer to seamless clinical data integration. Game-changing stuff! ??

?? ?? News for everyone involved in healthcare data cleaning and Electronic Health Record (EHR) systems! ?? Yonalink successfully used AI to map and stream data from EHR-to-EDC (i.e. clinical trial database) in real time across 21 medical centers! ?? 93% of the data was mapped and transferred with 100% accuracy of information! ?? This is a massive breakthrough that gets us one step closer to seamless clinical data integration. Game-changing stuff! ??

Big news ??, healthcare data fam! SEQSTER and Atropos Health are teaming up to make clinical trials MORE INCLUSIVE and EFFICIENT! Here's the scoop: We're joining forces to build turnkey #patient registries that generate evidence for drug development in under 48 hours! This normally takes a year and millions of dollars, so it's a game-changer for everyone. Underrepresented populations often miss out on clinical trials, leading to biased results. Our partnership aims to fix that by bringing diverse real-world data into the drug development process. ? SEQSTER's platform will integrate with Atropos Health's AI-powered tools like Geneva OS and ChatRWD, further streamlining the process. This isn't just about speed; it's about getting life-saving treatments to the people who need them most, faster. What does this mean for you? Healthcare systems and #lifescience companies: Save time and money on registry deployment and gain deeper insights from diverse populations. Patients: Get access to potentially life-saving treatments sooner, and have a greater say in research that affects your health. Everyone: A more equitable and efficient healthcare system that benefits everyone. Ready to join us on this mission? Let's chat! #ClinicalTrials #RealWorldData #EquityInHealthcare #SEQSTER #AtroposHealth #Partnership #Healthcare #ClinicalTrials #Equity #Data #AI #GenevaOS #ChatRWD ? Ardy Arianpour ?Brigham Hyde Kris Karson Raymie McFarland

Insights from our latest blog post on Keya Medical's AI-based CT-FFR analysis research and peer-reviewed publications. Our blog post provides a comprehensive overview of DEEPVESSEL FFR validation studies, showcasing its clinical performance, and impact on patient management. #CardiovascularHealth #MedicalInnovation #AIResearch #DEEPVESSELFFR #HealthTech #KeyaMedical #ADAPTStudy #ClinicalValidation #PeerReviewedPublications